http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150040565-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-24 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00 |
filingDate | 2013-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2015-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20150040565-A |
titleOfInvention | A pharmaceutical composition for preventing or treating Spinal Muscular Atrophy |
abstract | The present invention provides a preventive and therapeutic agent for spinal muscular atrophy comprising hnRNP M or a polynucleotide encoding the same. According to the present invention, hnRNP M increases mRNA formation of exon 7-containing forms upon selective splicing of SMN2 pre-mRNA. The composition of the present invention can prevent and treat spinal muscular atrophy using SMN2 pre-mRNA. |
priorityDate | 2013-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 310.